NCT01324635 2025-05-02
Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors
Thomas Jefferson University
Phase 1 Terminated
Clinical Trials
4 trialsNCT02717455 2024-04-25
PBTC-047
Pediatric Brain Tumor Consortium
Phase 1 Completed
NCT00859222 2017-03-14
LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
Dana-Farber Cancer Institute
Phase 1/2 Completed
NCT00848523 2010-07-16
Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors
Neurological Surgery, P.C.
Phase 2 Terminated